Search - tctmd.com

Displaying 101 - 120 of 129

Sort: Relevancy | Date

News Daily News

JACC Letter: Hypothermia Therapy May Increase Stent Thrombosis Risk

L.A. McKeown

January 06, 2013

News Daily News

Intracoronary ACE Inhibitor Reduces Microvascular Damage in Elective PCI

Yael L. Maxwell

January 06, 2013

News Conference News TCT 2012

REOPEN-AMI: Addition of Adenosine to Thrombus Aspiration Enhances PCI Outcomes

October 24, 2012

News Daily News

FAME Substudy: FFR-Guided PCI Just as Beneficial for Women as Men

October 17, 2012

News Daily News

PLATO Substudy: Ticagrelor Associated with Less Bleeding, Infection, Death than Clopidogrel after CABG

September 27, 2012

News Conference News ESC 2012

Noninvasive CT Angiography Plus CT Perfusion Shows Power to Diagnose Ischemic Lesions

August 28, 2012

News Daily News

La Medición de la Presión Sin Adenosina es Comparable a la FFR

Yael L. Maxwell

July 27, 2012

News Daily News

Adenosine-Free Pressure Measurement Comparable to FFR

Yael L. Maxwell

July 27, 2012

News Daily News

Ischemic Preconditioning Limits Contrast-Induced Kidney Damage

Caitlin E. Cox

July 02, 2012

News Daily News

Coronary Reactivity Testing Relatively Safe in High-Risk Women Without CAD

June 25, 2012

News Daily News

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

Caitlin E. Cox

June 07, 2012

News Conference News EuroPCR 2012

Mixed Results Shown with Adenosine-Free Pressure Measurement vs. FFR

Jason Kahn

May 16, 2012

News Daily News

Switching to Non-CYP3A4-Metabolized Statins May Reduce High Platelet Reactivity

April 25, 2012

News Daily News

TARGET-CABG Published: Waiting Period to CABG Flexible Per Platelet Function Test

Yael L. Maxwell

March 15, 2012

News Daily News

Mixed IMPACT for Cardiac MRI: More Sensitive Than SPECT, But Less Specific

March 07, 2012

News Daily News

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

L.A. McKeown

December 08, 2011

News Conference News

Adenosine-Free Pressure Measurement Found Equivalent to FFR

L.A. McKeown

December 01, 2011

News Industry News

Instantaneous wave-free ratio, a pressure-only measure of stenosis severity, is comparable to FFR without the use of adenosine

November 10, 2011

News Industry News

Volcano Corporation Announces Upcoming Presentation of Late-Breaking Clinical Trial Results and FFR Product Launch at TCT 2011

November 04, 2011

News Daily News

Meta-analysis: Intracoronary vs. IV Abciximab Improves Survival in STEMI Patients

L.A. McKeown

November 01, 2011

Advertisement

JACC Letter: Hypothermia Therapy May Increase Stent Thrombosis Risk

Intracoronary ACE Inhibitor Reduces Microvascular Damage in Elective PCI

REOPEN-AMI: Addition of Adenosine to Thrombus Aspiration Enhances PCI Outcomes

FAME Substudy: FFR-Guided PCI Just as Beneficial for Women as Men

PLATO Substudy: Ticagrelor Associated with Less Bleeding, Infection, Death than Clopidogrel after CABG

Noninvasive CT Angiography Plus CT Perfusion Shows Power to Diagnose Ischemic Lesions

La Medición de la Presión Sin Adenosina es Comparable a la FFR

Adenosine-Free Pressure Measurement Comparable to FFR

Ischemic Preconditioning Limits Contrast-Induced Kidney Damage

Coronary Reactivity Testing Relatively Safe in High-Risk Women Without CAD

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

Mixed Results Shown with Adenosine-Free Pressure Measurement vs. FFR

Switching to Non-CYP3A4-Metabolized Statins May Reduce High Platelet Reactivity

TARGET-CABG Published: Waiting Period to CABG Flexible Per Platelet Function Test

Mixed IMPACT for Cardiac MRI: More Sensitive Than SPECT, But Less Specific

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

Adenosine-Free Pressure Measurement Found Equivalent to FFR

Instantaneous wave-free ratio, a pressure-only measure of stenosis severity, is comparable to FFR without the use of adenosine

Volcano Corporation Announces Upcoming Presentation of Late-Breaking Clinical Trial Results and FFR Product Launch at TCT 2011

Meta-analysis: Intracoronary vs. IV Abciximab Improves Survival in STEMI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content